Healthcare -
Biotechnology - NASDAQ - US
$ 29.95
-2.25 %
$ 3.6 B
Market Cap
-10.36
P/E
RNA - STOCK-BASED COMPENSATION
Stock-based Compensation RNA - Avidity Biosciences, Inc.
38.2 M
LAST VALUE
49.70%
2 YEAR CAGR
263.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR